Comparison of Sonograms and Liver Histologic Findings in Patients with Chronic Hepatitis C Virus Infection

Size: px
Start display at page:

Download "Comparison of Sonograms and Liver Histologic Findings in Patients with Chronic Hepatitis C Virus Infection"

Transcription

1 Comparison of Sonograms and Liver Histologic Findings in Patients with Chronic Hepatitis C Virus Infection Rosalyn Kutcher, MD, Gail S. Smith, MD, Filiz Sen, MD, Scott F. Gelman, MD, Sumi Mitsudo, MD, Swan N. Thung, MD, John F. Reinus, MD Gray scale ultrasonographic images of the liver were correlated with histologic findings in patients with chronic hepatitis C virus infection. The gray scale patterns of 64 livers with chronic hepatitis C virus infection were categorized as normal, fatty, fibrofatty, fibrotic, or inflammatory and were graded as mild, moderate, or severe. Liver biopsy specimens also were analyzed for the presence of fat, inflammation, and fibrosis and graded similarly. No correlation was found between fatty and fibrofatty sonographic findings with any of the three histologic patterns. Correlations were found between fibrotic sonographic findings and both fibrotic and inflammatory histologic findings (r = 0.27; P = 0.03). lthough some pathologic features of liver disease were detected by ultrasonography, no useful correlation was noted between results of sonography and histologic examination. KEY WORDS: Hepatitis C virus; Liver, ultrasonography; Infection, hepatitic C. H epatitis C virus is the most common cause of chronic hepatitis in the United States. 1 In patients with chronic HCV infection, REVITIONS HCV, Hepatitis C virus; LT, lanine aminotransferase; SD, Standard deviation; ULN, Upper limit of normal Received July 31, 1997, from the Departments of Radiology (R.K., G.S.S.), Pathology (F.S., S.M.), and Medicine, Division of Gastroenterology (S.F.G., J.F.R.) The lbert Einstein College of Medicine and Montefiore Medical Center, ronx, New York; and The Lillian and Henry Stratton Hans Popper Department of Pathology, The Mount Sinai Medical Center, New York, New York. Revised manuscript accepted for publication February 9, ddress correspondence and reprint requests to Rosalyn Kutcher, MD, Department of Radiology, The lbert Einstein College of Medicine and Montefiore Medical Center, 111 East 210th Street, ronx, New York assessments of the severity of inflammatory liver injury (grade) and the degree of hepatic scarring (stage) are used to guide clinical management. 2 Gray scale ultrasonography has been reported to detect histologic features of chronic liver disease We compared retrospectively the gray scale liver images and histologic results in hepatitis C patients evaluated with sonographically guided liver biopsy to see if any correlation existed between sonographic and biopsy findings. If a positive correlation did exist, ultrasonography could be an important costeffective means of monitoring the disease in these patients. MTERILS ND METHODS Over a four year period ( ), 77 patients with chronic HCV infection and a positive anti-hcv antibody test (ELIS-2, Ortho-Diagnostics, Raritan, NJ) underwent percutaneous ultrasonographically 1998 by the merican Institute of Ultrasound in Medicine J Ultrasound Med 17: , /98/$3.50

2 322 CHRONIC HEPTITIS C VIRUS INFECTION J Ultrasound Med 17: , 1998 guided liver biopsy at our institution. Sixty-four of these patients formed our study population. Ultrasonograms, liver biopsy results, and clinical information were available for this group. ll images of the liver were acquired with cuson XP 10 and 128 units (cuson, Mountain View, C) using V4, V328, V3.5, or C366 transducers. Two or three core liver biopsies were obtained from the anterior segment of the right lobe in each patient using an 18 gauge needle (ard iopty or Magnum assembly, C.R. ard, Covington, G). Patient age, sex, serum LT level, sonographic size and texture of the liver, and liver histologic findings were reviewed. Size was determined by standard measurement of cranial to caudal length in the right midaxillary line. Sonographic images were classified simultaneously by two blinded readers (R.K., G.S.) as having normal, fatty, fibrofatty, fibrotic, or inflammatory patterns. liver was considered fatty if it demonstrated increased echogenicity, loss of portal venule walls, closely packed echoes, and decreased through-transmission. liver was considered fibrotic if it demonstrated a coarsened echotexture with a pinhead pattern but with preservation of the diaphragm. fibrofatty liver had both fibrotic and fatty features. liver was considered inflammatory if echogenic portal triads were observed in a hypoechoic liver or preservation of portal triads was noted in a background of fatty infiltration. 5,8 If any features of cirrhosis were present, including an irregular contour or nodularity, the liver disease was graded as severe (3) fibrosis. Grading was otherwise done subjectively for degree of severity of the various ultrasonographic patterns. fter the images of the liver were categorized appropriately on the basis of the sonographic pattern, the images within the given category were then graded subjectively on a spectrum as mild (1), moderate (2), or severe (3). iopsy specimens were examined blindly for the presence or absence of steatosis, inflammation, and fibrosis and were graded using the method of Desmet and coworkers. 11 Statistical comparison of sonographic patterns with corresponding histologic findings was performed using a Spearman rank correlation coefficient. Results from a subset of 35 patients with endstage renal disease or a history of end-stage renal disease and a functioning renal allograft were analyzed separately by a Wilcoxon rank sum test for differences in sonographic and histologic findings. ecause biopsy specimens from 12 of these patients were examined by two pathologists (F.S., S.N.T.) separately, the histologic results from these specimens were analyzed for correlation by an intraclass correlation coefficient. RESULTS Clinical evaluations, sonograms, and liver biopsy specimens from 64 patients (39 male, 25 female) aged 17 to 67 years (mean, 43.9 ± 11.6 SD; median, 44 years) were analyzed (Figs. 1 to 3). Liver size was 12 to 20.2 cm (mean, 15.2 cm ± 2 SD). LT values were one to 68 times the ULN (which equaled 40 units) with a mean of 2.9 times the ULN and a median of one times the ULN (54.8%). Thirty-five patients had end-stage renal disease, four had a history of alcohol abuse, two had biopsy-proved cirrhosis, and one had congestive heart failure. Two patients had ascites; Figure 1, Normal liver. Longitudinal ultrasonogram of the right lobe of the liver. Pathologic findings normal., Ultrasonogram: normal; pathologic findings: mild inflammation, mild fibrosis.

3 J Ultrasound Med 17: , 1998 KUTCHER ET L 323 none had hepatoma. No significant clinical history was present in the remaining 22 patients. Correlation was found between abnormal serum levels and histologic inflammation (r = 0.3, P < 0.01) in study patients. Ultrasonographic and histologic findings are presented in Table 1. Note that no sonographic categories were considered inflammatory. No correlation was found between the fatty or fibrofatty patterns on ultrasonography and the histologic findings of steatosis, fibrosis, or inflammation. However, a correlation was found between the fibrotic pattern on ultrasonography and the presence of fibrosis and inflammation at histologic examination (r = 0.27, P = 0.03). In addition, no correlation was noted between grade of fibrosis on ultrasonography and grade of fibrosis on histologic examination. n inverse correlation was observed between increasing liver size and fibrotic pattern on ultrasonography (r = 0.33, P < 0.01). This is expected since the liver shrinks as it becomes increasingly fibrotic or cirrhotic. similar correlation could not be made between liver size and the presence of fibrosis at histologic examination. The reason for this lack of correlation remains unclear, but it may be due to sampling error. In the subset of 35 patients with endstage renal disease, no additional correlation between sonographic findings and histologic findings was present. In the group of 12 patients in whom the biopsy specimens were examined by two pathologists separately, poor interobserver correlation was noted in grading of inflammation and fibrosis (Table 2). DISCUSSION The degree and type of liver injury in patients with acute or chronic liver disease has been difficult to evaluate using ultrasonography, although gray scale criteria for the diagnosis of hepatic inflammation, scarring, and fatty infiltration have been established. We used these criteria in our analysis of sonograms in patients with chronic HCV infection, 3 10 as described in the Materials and Methods section. The difference between fatty, fibrofatty, and fibrotic patterns often was difficult to perceive sonographically. Similarly, the severity of the patterns occurred over a continuous spectrum and was difficult to grade. The ultrasonongraphic pattern of inflammation is the most difficult to perceive, and none of the gray scale images in our series demonstrated either a hypoechoic liver or preserved portal triads. 4,9 lthough these variable gray scale patterns have been described to be typical of fat, fibrosis, and inflammation, this study suggests that these diagnoses are not entirely accurate in patients with chronic HCV infection. When a gray scale sonographic diagnosis of a fibrofatty or fatty liver was made, for example, fat or fibrosis was not necessarily present histologically, and often associated inflammatory changes were present that were not detected at all by ultrasonography. No patient had an inflammatory component on ultrasonography, although 56 patients had this clinically important finding on biopsy. Equally disturbing was the correlation between fibrosis on sonography and the presence of histologic inflammation. Fibrosis is usually a permanent change, whereas inflammation implies an active Figure 2, Ultrasonogram: Mild fatty liver, some loss of portal venule walls, but preservation of diaphragm. Pathologic findings: Moderate inflammation, mild fibrosis, no steatosis., Ultrasonogram: Moderate fatty liver, loss of portal venule walls, tightly packed echoes, and some loss of diaphragm. Pathologic findings: Mild inflammation, mild fibrosis, mild steatosis.

4 324 CHRONIC HEPTITIS C VIRUS INFECTION J Ultrasound Med 17: , 1998 Figure 3, Ultrasonogram: Mild fibrotic liver, coarsened texture with areas of pinhead echoes. Pathologic findings: Moderate inflammation, mild fibrosis, mild steatosis., Ultrasonogram: Severe fibrosis (immediately post biopsy), nodular pattern. Pathologic findings (two readers): mild to severe inflammation, no fibrosis, no steatosis. but potentially reversible process that may resolve without leaving any residual structural abnormality. Two limitations of this study are that it was a retrospective study, and prospective liver evaluation during scanning would likely allow for more accurate parenchymal analysis. Over the 4 year period of data accumulation, equipment and transducers improved, with superior imaging of the liver being possible in the more recent cases. Nevertheless, this study demonstrates that, at the present time, gray scale ultrasonography cannot be used as a method of grading or staging chronic HCV infection, and, by inference, other inflammatory liver diseases with the same histologic abnormalities. ppropriate management of HCV infection requires accurate grading and staging; chronic inflammation with only minimal fibrosis and small amounts of hepatic iron favors a good response to therapy with alpha-interferon 2. iopsy is equally important in the care of patients with other inflammatory liver diseases, many of which cannot be diagnosed accurately without examination of a liver biopsy specimen. correlation was found between elevated serum LT levels and the presence of inflammation on histologic examination. This finding is consistent with the results of other studies, although it is considered to be unreliable by hepatologists, as active disease can be found in patients with low or normal LT levels. It is widely recognized that some variation will occur in interpretation of liver biopsy findings from observer to observer. This was certainly demonstrated in the 12 biopsy specimens that were evaluated by the two pathologists in our study (Table 2). sampling error of up to 10% is accepted for liver biopsies in some diseases. 4 This fact and the findings in our study do raise some concern regarding use of pathologic findings as the gold standard. Since a large portion of our study population had end-stage renal disease, we examined this group as a subset to determine if they had any unique characteristics. Previous studies have shown that HCV infection is not made worse by hemodialyisis or renal transplantation and associated immunosuppression. 10 Findings in the subset of patients with end-stage renal disease evaluated in our study were not different from those in the rest of the study population. Slightly more fat was detected by ultrasonography and biopsy in these patients, a finding that might be related to chronic immunosuppressive therapy with prednisone. Table 1: Comparison of Sonographic Pattern with Histologic Pattern Histologic Pattern (n) Ultrasound (mild moderate severe) Pattern (n) Normal Steatosis Inflammation Fibrosis Normal (14) (5 0 0) (8 2 2) (4 3 0) Fatty (6) (2 2 0) (1 4 0) (3 1 0) Fibrofatty (16) (6 2 2) (7 6 1) (8 3 2) Fibrotic (28) (10 3 0) (9 10 6) (7 7 7)

5 J Ultrasound Med 17: , 1998 KUTCHER ET L 325 Table 2: Interobserver Variation of Histologic Interpretation in 12 Patients fter Double Reading ICC* Path (I) = 0.07 ICC Path (F) = 0.21 ICC Path (S) = 0.78 P < *Intraclass correlation coefficient. I, Inflammation; F, fibrosis; S, fat. In conclusion, although microscopic features of liver disease in patients with chronic HCV infection were detected by ultrasonography, no consistent correlation between sonographic and histologic findings was found, suggesting that ultrasonographic imaging is unreliable for grading and staging the degree of liver damage in chronic HCV infection. REFERENCES Very poor Not correlative Very high 3. Lindnor KD, ru C, Jorgensen R, et al: The role of ultrasonography and automatic needle biopsy in outpatient percutaneous liver biopsy. Hepatology 23:1079, Joseph E: Diffuse liver disease. Clin Diagn Ultrasound 29:1, Taylor KJW, Riely C, Hammers L, et al: Quantitative US attenuation in normal liver and in patients with diffuse liver disease: Importance of fat. Radiology 160:65, Kester NL, LaFortune M, ubin, et al: Focal sparing of liver parenchyma. J Ultrasound Med 15:89, Needleman L, Kurtz, Rifkin MD, et al: Sonography of diffuse benign liver disease. JR 146:1011, Taylor KJW, Gorelick FS, Rosenfield T, et al: Ultrasonography of alcoholic liver disease with histological correlation. Radiology 141:157, Zwiebel WJ: Sonographic diagnosis of diffuse liver disease. Semin Ultrasound CT MRI 16:8, Rosen HR, Friedman LS, Martin P: Hepatitis C and the renal transplant patient. Semin Dialysis 9:39, Desmet VJ, Gerber M, Hoofnagle JH, et al: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513, McQuillan GM, lter MJ, Everhart JE: Viral hepatitis. In Everhart JE (Ed): Digestive Diseases in the United States: Epidemiology and Impact. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes, and Digestive and Kidney Diseases. Washington, DC, US Government Printing Office, 1994; NIH publication no p National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes, and Digestive and Kidney Diseases. Washington, DC, US Government Printing Office, 1997 (in press)

Review: How to work up your patient with Hepatitis C

Review: How to work up your patient with Hepatitis C Review: How to work up your patient with Hepatitis C You screened your patient, and now the HCV antibody test is positive. What do you do next? The antibody test only means they have been exposed to HCV.

More information

The State of the Liver in the Adult Patient after Fontan Palliation

The State of the Liver in the Adult Patient after Fontan Palliation The State of the Liver in the Adult Patient after Fontan Palliation Fred Wu, M.D. Boston Adult Congenital Heart Service Boston Children s Hospital/Brigham & Women s Hospital 7 th National Adult Congenital

More information

Cirrhosis and HCV. Jonathan Israel M.D.

Cirrhosis and HCV. Jonathan Israel M.D. Cirrhosis and HCV Jonathan Israel M.D. Outline Relationship of fibrosis and cirrhosisprevalence and epidemiology. Sequelae of cirrhosis Diagnosis of cirrhosis Effect of cirrhosis on efficacy of treatment

More information

Geir Folvik, MD Division of Gastroenterology Department of Medicine, Haukeland University Hospital Bergen, Norway 30.11.2015

Geir Folvik, MD Division of Gastroenterology Department of Medicine, Haukeland University Hospital Bergen, Norway 30.11.2015 Benign liver diseases Geir Folvik, MD Division of Gastroenterology Department of Medicine, Haukeland University Hospital Bergen, Norway 30.11.2015 1 Agenda Benign focal liver lesions Fatty liver disease

More information

Surveillance for Hepatocellular Carcinoma

Surveillance for Hepatocellular Carcinoma Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April

More information

Transmission of HCV in the United States (CDC estimate)

Transmission of HCV in the United States (CDC estimate) Transmission of HCV in the United States (CDC estimate) Past and Future US Incidence and Prevalence of HCV Infection Decline among IDUs Overall incidence Overall prevalence Infected 20+ years Armstrong

More information

BACKGROUND MEDIA INFORMATION Fast facts about liver disease

BACKGROUND MEDIA INFORMATION Fast facts about liver disease BACKGROUND MEDIA INFORMATION Fast facts about liver disease Liver, or hepatic, disease comprises a wide range of complex conditions that affect the liver. Liver diseases are extremely costly in terms of

More information

Approach to Abnormal Liver Tests

Approach to Abnormal Liver Tests Approach to Abnormal Liver Tests Naga P. Chalasani, MD, FACG Professor of Medicine and Cellular & Integrative Physiology Director, Division of Gastroenterology and Hepatology Indiana University School

More information

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient

More information

Noninvasive Means of Diagnosing Liver Fibrosis in Hepatitis C*

Noninvasive Means of Diagnosing Liver Fibrosis in Hepatitis C* 530 BJID 2007; 11 (December) Noninvasive Means of Diagnosing Liver Fibrosis in Hepatitis C* Eduardo Sellan Lopes Gonçales, Adriana Flávia Feltrim Angerami and Fernando Lopes Gonçales Junior Study Group

More information

Patterns of abnormal LFTs and their differential diagnosis

Patterns of abnormal LFTs and their differential diagnosis Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Summary liver function / liver function

More information

Non-alcoholic fatty liver disease: Prognosis and Treatment

Non-alcoholic fatty liver disease: Prognosis and Treatment Non-alcoholic fatty liver disease: Prognosis and Treatment Zachary Henry, M.D. Assistant Professor UVA Gastroenterology & Hepatology October 28, 2015 Overview Case Presentation Prognosis Effects of fibrosis

More information

EVALUATION OF LIVER FIBROSIS BY FIBROSCAN

EVALUATION OF LIVER FIBROSIS BY FIBROSCAN EVALUATION OF LIVER FIBROSIS BY FIBROSCAN M. Beaugrand Service d Hépatologied Hopital J. Verdier BONDY 93143 et Université Paris XIII DRESDEN 13.10.2007 ASSESSMENT OF FIBROSIS : WHY? Management of individual

More information

Update on Hepatitis C. Sally Williams MD

Update on Hepatitis C. Sally Williams MD Update on Hepatitis C Sally Williams MD Hep C is Everywhere! Hepatitis C Magnitude of the Infection Probably 8 to 10 million people in the U.S. are infected with Hep C 30,000 new cases are diagnosed annually;

More information

Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call. March 16, 2011

Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call. March 16, 2011 Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call March 16, 2011 Case Presentations Kansas City Free Health Clinic Carilion Clinic Didactic Session Challenges in Determining HCV Treatment

More information

NASH: It is not JUST a Fatty Liver. Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center

NASH: It is not JUST a Fatty Liver. Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center NASH: It is not JUST a Fatty Liver Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center Stages of Fatty Liver Disorders Fatty Liver 16-35% of Western

More information

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Liver Transplantation for Hepatocellular Carcinoma John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Hepatocellular Carcinoma HCC is the 5th most common

More information

Evaluation and Follow-up of Fetal Hydronephrosis

Evaluation and Follow-up of Fetal Hydronephrosis Evaluation and Follow-up of Fetal Hydronephrosis Deborah M. Feldman, MD, Marvalyn DeCambre, MD, Erin Kong, Adam Borgida, MD, Mujgan Jamil, MBBS, Patrick McKenna, MD, James F. X. Egan, MD Objective. To

More information

Recanalized Umbilical Vein in the Presence of Cirrhosis-Induced Portal Hypertension

Recanalized Umbilical Vein in the Presence of Cirrhosis-Induced Portal Hypertension Recanalized Umbilical Vein in the Presence of Cirrhosis-Induced Portal Hypertension Audrey Galey RDMS, RVT, Mary Grace Renfro RDSM, RVT, Lindsey Simon, RVT March 22, 2013 2 Abstract A recanalized umbilical

More information

Sonographic Demonstration of Couinaud s Liver Segments

Sonographic Demonstration of Couinaud s Liver Segments PICTORIL ESSY Sonographic Demonstration of Couinaud s Liver Segments Dean Smith, MD, FRCPC, Donal Downey, M, Ch, FRCPC, lison Spouge, MD, FRCPC, Sue Soney, RT, RDMS, RCMS The segmental localization of

More information

HIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK

HIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK HIV and Hepatitis Co-infection Martin Fisher Brighton and Sussex University Hospitals, UK Useful References British HIV Association 2010 http://www.bhiva.org/documents/guidelines/hepbc/2010/ hiv_781.pdf

More information

Management of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok

Management of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok Management of hepatitis C: pre- and post-liver transplantation Piyawat Komolmit Bangkok Liver transplantation and CHC Cirrhosis secondary to HCV is the leading cause of liver transplantation in the US

More information

Amylase and Lipase Tests

Amylase and Lipase Tests Amylase and Lipase Tests Also known as: Amy Formal name: Amylase Related tests: Lipase The Test The blood amylase test is ordered, often along with a lipase test, to help diagnose and monitor acute or

More information

Alanine aminotransferase (serum, plasma)

Alanine aminotransferase (serum, plasma) Alanine aminotransferase (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Alanine aminotransferase (ALT) 1.2 Alternative names Systematic name L alanine:2 oxoglutarate aminotransferase

More information

MRI of Bone Marrow Radiologic-Pathologic Correlation

MRI of Bone Marrow Radiologic-Pathologic Correlation MRI of Bone Marrow Radiologic-Pathologic Correlation Marilyn J. Siegel, M.D. Mallinckrodt Institute of Radiology Washington University School of Medicine St. Louis, MO and Visiting Scientist, AFIP, Washington,

More information

The Epidemiology of Hepatitis A, B, and C

The Epidemiology of Hepatitis A, B, and C The Epidemiology of Hepatitis A, B, and C Jamie Berkes M.D. University of Illinois at Chicago jberkes@uic.edu Epidemiology: Definitions The study of the incidence and prevalence of diseases in large populations

More information

BURDEN OF LIVER DISEASE IN BRAZIL

BURDEN OF LIVER DISEASE IN BRAZIL BURDEN OF LIVER DISEASE IN BRAZIL Burden of Liver Disease in Europe Blachier et al. J Hepatol 58:593, 2013 Review of 260 epidemiologic studies of the 5 previous years Cirrhosis is responsible for 170.000

More information

LIVER FUNCTION TESTS AND STATINS

LIVER FUNCTION TESTS AND STATINS LIVER FUNCTION TESTS AND STATINS Philippe J. Zamor and Mark W. Russo Current Opinion in Cardiology 2011,26:338 341 SUMMARY Purpose of review: To discuss recent data on statins in patients with elevated

More information

Differential Diagnosis of NAFLD- A Short Summary:

Differential Diagnosis of NAFLD- A Short Summary: Differential Diagnosis of NAFLD- A Short Summary: Almost a fifth of our general pediatric population is now classified as overweight in the United States. When such children present with elevated liver

More information

LIVER CANCER AND TUMOURS

LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS Healthy Liver Cirrhotic Liver Tumour What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood

More information

GT-020 Phase 1 Clinical Trial: Results of Second Cohort

GT-020 Phase 1 Clinical Trial: Results of Second Cohort GT-020 Phase 1 Clinical Trial: Results of Second Cohort July 29, 2014 NASDAQ: GALT www.galectintherapeutics.com 2014 Galectin Therapeutics inc. Forward-Looking Statement This presentation contains, in

More information

PREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto

PREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto PREVENTION OF HCC BY HEPATITIS C TREATMENT Morris Sherman University of Toronto Pathogenesis of HCC in chronic hepatitis C Injury cirrhosis HCC Injury cirrhosis HCC Time The Ideal Study Prospective randomized

More information

MANAGEMENT OF LIVER CIRRHOSIS

MANAGEMENT OF LIVER CIRRHOSIS MANAGEMENT OF LIVER CIRRHOSIS Information Leaflet Your Health. Our Priority. Page 2 of 6 What is cirrhosis? Cirrhosis is a result of long-term, continuous damage to the liver and may be due to many different

More information

Prognosis of Very Large First-Trimester Hematomas

Prognosis of Very Large First-Trimester Hematomas Case Series Prognosis of Very Large First-Trimester Hematomas Juliana Leite, MD, Pamela Ross, RDMS, RDCS, A. Cristina Rossi, MD, Philippe Jeanty, MD, PhD Objective. The aim of this study was to evaluate

More information

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Epidemiology of Hepatitis C Infection Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Worldwide Prevalence of Hepatitis C 10% No data available WHO.

More information

What to Expect from Intestinal Ultrasonography

What to Expect from Intestinal Ultrasonography 261) What to Expect from Intestinal Ultrasonography Červenková J., Steyerová P. Charles University in Prague, First Faculty of Medicine and General Teaching Hospital, Department of Radiology, Prague, Czech

More information

Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs

Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs Last update: February 23, 2015 Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs Please see healthpartners.com for Medicare coverage criteria. Table of Contents 1. Harvoni 2. Sovaldi

More information

LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis

LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis LYMPHOMA IN DOGS Lymphoma is a relatively common cancer in dogs. It is a cancer of lymphocytes (a type of white blood cell) and lymphoid tissues. Lymphoid tissue is normally present in many places in the

More information

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis HEPATITIS WEB STUDY Acute C Virus Infection: Epidemiology, Clinical Features, and Diagnosis H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School

More information

Abnormal Liver Function. Dr William Alazawi MA(Cantab) PhD MRCP Senior Lecturer and Consultant in Hepatology Queen Mary, University of London

Abnormal Liver Function. Dr William Alazawi MA(Cantab) PhD MRCP Senior Lecturer and Consultant in Hepatology Queen Mary, University of London Abnormal Liver Function Dr William Alazawi MA(Cantab) PhD MRCP Senior Lecturer and Consultant in Hepatology Queen Mary, University of London Does Liver Disease Matter? Mortality in England & Wales Liver-related

More information

2.1 AST can be measured in heparin plasma or serum. 3 Summary of clinical applications and limitations of measurements

2.1 AST can be measured in heparin plasma or serum. 3 Summary of clinical applications and limitations of measurements Aspartate aminotransferase (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Aspartate aminotransferase (AST) 1.2 Alternative names Systematic name L aspartate:2 oxoglutarate aminotransferase

More information

Soft Tissue Diffuse Neurofibromas

Soft Tissue Diffuse Neurofibromas ase Series Soft Tissue Diffuse Neurofibromas Sonographic Findings Wen hen, MD, Jian-Wen Jia, MD, Jin-Rui Wang, MD Objective. The purpose of this study was to describe the sonographic findings of soft tissue

More information

UCLA Asian Liver Program

UCLA Asian Liver Program CLA Program Update Program Faculty Myron J. Tong, PhD, MD Professor of Medicine Hepatology Director, Asian Liver Program Surgery Ronald W. Busuttil, MD, PhD Executive Chair Department of Surgery Director,

More information

LIVER. Update on Staging of Fibrosis and Cirrhosis. Staging and Liver Fibrosis. Stage is more than liver fibrosis

LIVER. Update on Staging of Fibrosis and Cirrhosis. Staging and Liver Fibrosis. Stage is more than liver fibrosis Linda Ferrell, MD Distinguished Professor Vice Chair Director of Surgical Pathology Dept of Pathology LIVER Update on Staging of Fibrosis and Cirrhosis Staging and Liver Fibrosis Two important concepts

More information

Non-invasive evaluation of liver fibrosis: current clinical use and next perspectives (chronic hepatitis C)

Non-invasive evaluation of liver fibrosis: current clinical use and next perspectives (chronic hepatitis C) Non-invasive evaluation of liver fibrosis: current clinical use and next perspectives (chronic hepatitis C) Paul Calès Liver and Gastroenterology department, University hospital & HIFIH laboratory, Angers

More information

After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH

After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH Professor of Medicine Department of Gastroenterology Director, Viral Hepatitis Center University of California San Francisco

More information

Prof. of Tropical Medicine Faculty of Medicine Alexandria University

Prof. of Tropical Medicine Faculty of Medicine Alexandria University prof. Dr. Ali El-Kady (MD) Prof. of Tropical Medicine Faculty of Medicine Alexandria University DRUGS THAT MAY CAUSE LIVER DYSFUNCTION DAMAGE The liver is the principal organ that is capable of converting

More information

HEPATITIS C. The Facts. Get Tested. Get Cured! Health

HEPATITIS C. The Facts. Get Tested. Get Cured! Health HEPATITIS C The Facts Get Tested. Get Cured! Health EVEN IF YOU FEEL HEALTHY, HEPATITIS C MAY BE DAMAGING YOUR LIVER. Your liver keeps you healthy in many ways, such as by removing toxins from your blood

More information

Liver Function Tests - The Downside

Liver Function Tests - The Downside KAPIL CHOPRA, MD 1 So I'm going to kickoff this course with the topic of abnormal liver function tests. To be very honest this is a huge topic. I think to do justice I'm going to try and touch on some

More information

Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine

Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease From : New England Journal of Medicine Volume 351:1521-1531, Number 15, Oct 7, 2004 馬 偕 紀 念 醫 院 一 般 內 科, 肝 膽 腸 胃 科 新 竹 分 院 陳 重

More information

What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic

What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic Introduction Elevated liver enzymes is often not a clinical problem by itself. However it is a warning

More information

NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN MEN WITH TYPE 2 DIABETES

NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN MEN WITH TYPE 2 DIABETES NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN MEN WITH TYPE 2 DIABETES D. Bakalov 1, M. Boyanov 1, G. Sheinkova 1, L. Vezenkova 1, G. Prodanova 2, V. Christov 1 1 Endocrinology Clinic 2 Sonography unit

More information

Sonographic Diagnosis of Ureteral Tumors

Sonographic Diagnosis of Ureteral Tumors Sonographic Diagnosis of Ureteral Tumors Irith Hadas-Halpern, MD, micur Farkas, MD, Michael Patlas, MD, Ibrahim Zaghal, MD, Shoshana Sabag-Gottschalk, MD, Drora Fisher, MD We present our experience with

More information

Hepatitis C. David Mutimer Queen Elizabeth Hospital Liver Unit Birmingham. Substance Misuse Treatment in the West Midlands. How can we reduce harm?

Hepatitis C. David Mutimer Queen Elizabeth Hospital Liver Unit Birmingham. Substance Misuse Treatment in the West Midlands. How can we reduce harm? Hepatitis C David Mutimer Queen Elizabeth Hospital Liver Unit Birmingham Substance Misuse Treatment in the West Midlands. How can we reduce harm? Birmingham October 19 th 2007 infection HCV Natural History

More information

Ovarian Torsion: Sonographic Evaluation

Ovarian Torsion: Sonographic Evaluation J Clin Ultrasound 17:327-332, June 1989 Ovarian Torsion: Sonographic Evaluation Mark A. Helvie, MD,* and Terry M. Silver, MDI Abstract: The sonographic and clinical findings of 13 patients with surgically

More information

LCD for Viral Hepatitis Serology Tests

LCD for Viral Hepatitis Serology Tests LCD for Viral Hepatitis Serology Tests Applicable CPT Code(s): 86692 Antibody; Hepatitis, Delta Agent 86704 Hepatitis B Core Antibody (HBcAb); Total 86705 Hepatitis B Core Antibody (HBcAb); IgM Antibody

More information

2015 Outpatient Chronic Hepatitis B Management

2015 Outpatient Chronic Hepatitis B Management 2015 Outpatient Chronic Hepatitis B Management Hepatitis B Hepatitis B Info 70% of acute infections are subclinical More severe symptoms when in addition to other liver disease Fulminant Hepatitis

More information

Hepatitis C Glossary of Terms

Hepatitis C Glossary of Terms Acute Hepatitis C A short-term illness that usually occurs within the first six months after someone is exposed to the hepatitis C virus (HCV). 1 Antibodies Proteins produced as part of the body s immune

More information

190.33 - Hepatitis Panel/Acute Hepatitis Panel

190.33 - Hepatitis Panel/Acute Hepatitis Panel 190.33 - Hepatitis Panel/Acute Hepatitis Panel This panel consists of the following tests: Hepatitis A antibody (HAAb), IgM antibody; Hepatitis B core antibody (HBcAb), IgM antibody; Hepatitis B surface

More information

Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality

Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality C. Tomas, MA Castel, E Roig, I. Vallejos, C. Plata, F. Pérez-Villa Cardiology Department,

More information

Comparative Levels of ALT, AST, ALP and GGT in Liver associated Diseases

Comparative Levels of ALT, AST, ALP and GGT in Liver associated Diseases Available online at wwwpelagiaresearchlibrarycom European Journal of Experimental Biology, 2013, 3(2):280-284 ISSN: 2248 9215 CODEN (USA): EJEBAU Comparative Levels of ALT, AST, ALP and GGT in Liver associated

More information

Commonly Asked Questions About Chronic Hepatitis C

Commonly Asked Questions About Chronic Hepatitis C Commonly Asked Questions About Chronic Hepatitis C From the American College of Gastroenterology 1. How common is the hepatitis C virus? The hepatitis C virus is the most common cause of chronic viral

More information

Viral Hepatitis A, B, and C

Viral Hepatitis A, B, and C Viral Hepatitis A, B, and C What is Hepatitis? Hepatitis means inflammation of the liver Elizabeth A. Bancroft, MD, SM Acute Communicable Disease Control County of Los Angeles Department of Public Health

More information

New IDSA/AASLD Guidelines for Hepatitis C

New IDSA/AASLD Guidelines for Hepatitis C NORTHWEST AIDS EDUCATION AND TRAINING CENTER New IDSA/AASLD Guidelines for Hepatitis C John Scott, MD, MSc Associate Professor, UW SoM Asst Director, Liver Clinic, Harborview Medical Center Presentation

More information

Ultrasonography of the Adrenal Glands CVM 6105 Kari L. Anderson, DVM, Diplomate ACVR Associate Clinical Professor of Veterinary Radiology

Ultrasonography of the Adrenal Glands CVM 6105 Kari L. Anderson, DVM, Diplomate ACVR Associate Clinical Professor of Veterinary Radiology 1: US of adrenal glands, KLA Ultrasonography of the Adrenal Glands CVM 6105 Kari L. Anderson, DVM, Diplomate ACVR Associate Clinical Professor of Veterinary Radiology Ultrasound has quickly become an important

More information

ELEMENTS FOR A PUBLIC SUMMARY. Overview of disease epidemiology. Summary of treatment benefits

ELEMENTS FOR A PUBLIC SUMMARY. Overview of disease epidemiology. Summary of treatment benefits VI: 2 ELEMENTS FOR A PUBLIC SUMMARY Bicalutamide (CASODEX 1 ) is a hormonal therapy anticancer agent, used for the treatment of prostate cancer. Hormones are chemical messengers that help to control the

More information

Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct)

Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct) Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct) Section 1 Service Details Service ID: 7540540 Service Comments: Referrer Alert: Service

More information

Albumin. Prothrombin time. Total protein

Albumin. Prothrombin time. Total protein Hepatitis C Fact Sheet February 2016 www.hepatitis.va.gov Laboratory Tests and Hepatitis If you have hepatitis C, your doctor will use laboratory tests to about learn more about your individual hepatitis

More information

Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease

Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease 80 Liver Disease and Obesity Liver disease biomarkers: Percent of adult population (United States)

More information

Hepatocellular Carcinoma: A Guide to Screening and Diagnosis

Hepatocellular Carcinoma: A Guide to Screening and Diagnosis February 2012 Hepatocellular Carcinoma: A Guide to Screening and Diagnosis Reid Merryman, Harvard Medical School Year III Agenda Hepatocellular carcinoma (HCC) introduction Index patient: clinical presentation

More information

Results Demographic profile of these children is shown in Table I.

Results Demographic profile of these children is shown in Table I. Prevalence of Antibody to Hepatitis C Virus in Pakistani Thalassaemics by Particle Agglutination Test Utilizing C 200 and C 22-3 Viral Antigen Coated Particles Pages with reference to book, From 269 To

More information

"Lucian Blaga"University Sibiu Faculty of Medicine Victor Papilian. EVALUATION OF LIVER FIBROSIS IN CHRONIC VIRAL HEPATITIS C. PhD thesis abstract

Lucian BlagaUniversity Sibiu Faculty of Medicine Victor Papilian. EVALUATION OF LIVER FIBROSIS IN CHRONIC VIRAL HEPATITIS C. PhD thesis abstract "Lucian Blaga"University Sibiu Faculty of Medicine Victor Papilian EVALUATION OF LIVER FIBROSIS IN CHRONIC VIRAL HEPATITIS C. PhD thesis abstract Scientific coordinator Prof. Dr. Mircea DEAC PhD student

More information

Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases

Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases M. Trauner, Division of Gastroenterology and Hepatology, Department of Internal Medicine, MUG Co- Investigator: H. Samonigg,

More information

Non-Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Non-Alcoholic Fatty Liver Disease Information for patients and families UHN Read this information to learn: what non-alcoholic fatty liver disease is what causes it how it s treated how to prevent it where

More information

Early Prostate Cancer: Questions and Answers. Key Points

Early Prostate Cancer: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:

More information

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Brochure More information from http://www.researchandmarkets.com/reports/1047385/ Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Description: Liver disease is a rapidly growing

More information

3/25/2014. April 3, 2014. Dennison MM, et al. Ann Intern Med. 2014;160:293 300.

3/25/2014. April 3, 2014. Dennison MM, et al. Ann Intern Med. 2014;160:293 300. April 3, 2014 3.6 million persons ever infected; 2.7 million chronic infections 1 Up to 75% unaware of status Transmitted through percutaneous exposure to infected blood Injection drug use (IDU) is the

More information

Incidence of Incidental Thyroid Nodules on Computed Tomography (CT) Scan of the Chest Performed for Reasons Other than Thyroid Disease

Incidence of Incidental Thyroid Nodules on Computed Tomography (CT) Scan of the Chest Performed for Reasons Other than Thyroid Disease International Journal of Clinical Medicine, 2011, 2, 264-268 doi:10.4236/ijcm.2011.23042 Published Online July 2011 (http://www.scirp.org/journal/ijcm) Incidence of Incidental Thyroid Nodules on Computed

More information

Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.

Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Male Breast Cancer Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Many people do not know that men can get breast

More information

Optimal imaging surveillance schedules after liver directed therapy for hepatocellular carcinoma

Optimal imaging surveillance schedules after liver directed therapy for hepatocellular carcinoma Optimal imaging surveillance schedules after liver directed therapy for hepatocellular carcinoma F. Edward Boas, MD, PhD; Bao Do, MD; John D. Louie, MD; Nishita Kothary, MD; Gloria L. Hwang, MD; William

More information

Preparation iagnostic Medical Sonographer Overview"

Preparation iagnostic Medical Sonographer Overview Diagnostic Medical Sonographer Overview The Field - Preparation - Specialty Areas - Day in the Life - Earnings - Employment - Career Path Forecast - Professional Organizations The Field Diagnostic imaging

More information

Living with HEP C. Facts about Hepatitis C

Living with HEP C. Facts about Hepatitis C Living with HEP C Facts about Hepatitis C IMPORTANT The information in this booklet is intended for people who are newly diagnosed with Hepatitis C (called Hep C for short). It can help you learn more

More information

HCV: Diagnostic Testing and Staging. HCV: Diagnostic Tests

HCV: Diagnostic Testing and Staging. HCV: Diagnostic Tests HCV: Diagnostic Testing and Staging HCV: Diagnostic Tests Necessary HCV Antibody HCV-RNA Genotype Not Necessary ALT IL28 B 1 ALT as a Sole Trigger for Screening Misses Some Infected Patients Patients*

More information

Estimation of Fetal Weight: Mean Value from Multiple Formulas

Estimation of Fetal Weight: Mean Value from Multiple Formulas Estimation of Fetal Weight: Mean Value from Multiple Formulas Michael G. Pinette, MD, Yuqun Pan, MD, Sheila G. Pinette, RPA-C, Jacquelyn Blackstone, DO, John Garrett, Angelina Cartin Mean fetal weight

More information

SHAHID AZIZ DO, FACOI.

SHAHID AZIZ DO, FACOI. SHAHID AZIZ DO, FACOI. ASSOCIATE CLINICAL PROFESSOR OF GI AND LIVER DISEASE. UT SOUTHWESTERN HEALTH SCIENCE CENTER, DALLAS ADJUNCT CLINICAL ASSISTANT PROFESSOR DEPT OF MEDICINE UNT HEALTH SCIENCE CENTER

More information

The most serious symptoms of this stage are:

The most serious symptoms of this stage are: The Natural Progression of Hepatitis C The natural history of hepatitis C looks at the likely outcomes for people infected with the virus if there is no medical intervention. However, the process of trying

More information

Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model

Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model J Clin Pathol 1996;49:465-469 Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model 465 V S Wong, D G D Wight, C R Palmer, G J M Alexander Department of Medicine,

More information

Case Study in the Management of Patients with Hepatocellular Carcinoma

Case Study in the Management of Patients with Hepatocellular Carcinoma Management of Patients with Viral Hepatitis, Paris, 2004 Case Study in the Management of Patients with Hepatocellular Carcinoma Eugene R. Schiff This 50-year-old married man with three children has a history

More information

Sonography of Partial-Thickness Quadriceps Tendon Tears With Surgical Correlation

Sonography of Partial-Thickness Quadriceps Tendon Tears With Surgical Correlation Article Sonography of Partial-Thickness Quadriceps Tendon Tears With Surgical Correlation Samuel La, MD, David P. Fessell, MD, John E. Femino, MD, Jon A. Jacobson, MD, David Jamadar, MB, BS, Curtis Hayes,

More information

EMERGING CLINICAL ISSUE: HEPATITIS C INFECTION IN HIV-INFECTED MEN WHO HAVE SEX WITH MEN

EMERGING CLINICAL ISSUE: HEPATITIS C INFECTION IN HIV-INFECTED MEN WHO HAVE SEX WITH MEN EMERGING CLINICAL ISSUE: HEPATITIS C INFECTION IN HIV-INFECTED MEN WHO HAVE SEX WITH MEN JUNE 2014 INTRODUCTION Approximately 3.2 million individuals in the United States are infected with chronic hepatitis

More information

HEPATITIS COINFECTIONS

HEPATITIS COINFECTIONS HEPATITIS COINFECTIONS Kenneth E. Sherman, MD, PhD Gould Professor of Medicine Director, Division of Digestive Diseases University of Cincinnati College of Medicine Disclosures (Activity w/i 12 months)

More information

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,

More information

Viral Hepatitis. 2009 APHL survey report

Viral Hepatitis. 2009 APHL survey report Issues in Brief: viral hepatitis testing Association of Public Health Laboratories May Viral Hepatitis Testing 9 APHL survey report In order to characterize the role that the nation s public health laboratories

More information

NUTRITION IN LIVER DISEASES

NUTRITION IN LIVER DISEASES NUTRITION IN LIVER DISEASES 1. HEPATITIS: Definition: - Viral inflammation of liver cells. Types: a. HAV& HEV, transmitted by fecal-oral route. b. HBV & HCV, transmitted by blood and body fluids. c. HDV

More information

Acute on Chronic Liver Failure: Current Concepts. Disclosures

Acute on Chronic Liver Failure: Current Concepts. Disclosures Acute on Chronic Liver Failure: Current Concepts Vandana Khungar, MD MSc Assistant Professor of Medicine University of Pennsylvania, Perelman School of Medicine September 20, 2015 None to declare Disclosures

More information

PREPARED BY THE CENTER FOR HEALTH LAW AND POLICY INNOVATION OF HARVARD LAW SCHOOL

PREPARED BY THE CENTER FOR HEALTH LAW AND POLICY INNOVATION OF HARVARD LAW SCHOOL Pennsylvania PREPARED BY THE CENTER FOR HEALTH LAW AND POLICY INNOVATION OF HARVARD LAW SCHOOL Pennsylvania Hepatitis C Virus (HCV) in Pennsylvania Prevalence + + Although state-wide data were unavailable,

More information

The degree of liver inflammation or damage (grade) Presence and extent of fatty liver or other metabolic liver diseases

The degree of liver inflammation or damage (grade) Presence and extent of fatty liver or other metabolic liver diseases ilearning about your health Liver Biopsy www.cpmc.org/learning What is a Liver Biopsy? A liver biopsy is a procedure where a specially trained doctor (typically a hepatologist, radiologist, or gastroenterologist)

More information

What does Hepatitis C mean to me as a CKD Patient?

What does Hepatitis C mean to me as a CKD Patient? What does Hepatitis C mean to me as a CKD Patient? Clinical Practice Guidelines for the Prevention, Diagnosis, Evaluation and Treatment of Hepatitis C in CKD Introduction Worldwide, about 170 million people

More information

CANCER OF THE LIVER HEPATOCELLULAR CARCINOMA

CANCER OF THE LIVER HEPATOCELLULAR CARCINOMA CANCER OF THE LIVER HEPATOCELLULAR CARCINOMA WHAT IS CANCER OF THE LIVER? Hepatocellular carcinoma is the most common form and it comes from the main type of liver cell, the hepatocyte. About 3 out 4

More information